Industry / United States
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Wal-Mart Expands Low-Price Prescription Drug Scheme
May 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Providing a small but welcome boost to the US generic drug market, Wal-Mart has expanded its low-priced prescription drug scheme. The world's largest retailer now offers a 90-day course of generic drug prescriptions for US$10, packs of brand-name over-the-counter (OTC) medicines for US$4, and has expanded its offerings of women's health products. As a result, consumers on low incomes and without health insurance will see significant savings to their pharmaceutical bills. Given the previous success of the scheme and this latest development, BMI expects Wal-Mart to continue rolling-out the offers in additional foreign